SS Kodex Consumer Discretionary ETF (266390)

Overview

Nexstim Plc is a pioneering medical technology company based in Helsinki, Finland, with a global reach that extends to Europe, North America, and other international territories. Founded in the year 2000, Nexstim has dedicated itself to the advancement of non-invasive brain stimulation technologies. Their innovative navigated transcranial magnetic stimulation (nTMS) technology, which is enhanced with 3D navigation, ensures precise and personalized targeting within the brain. This precision facilitates the effective treatment of various conditions and supports the mapping of critical brain areas prior to surgery. Nexstim's groundbreaking work primarily benefits universities and teaching hospitals around the world, furnishing these institutions with advanced diagnostic and therapeutic systems.

Products and Services

• Navigated Brain Therapy (NBT) system

The Navigated Brain Therapy system is a cutting-edge solution designed for the treatment of major depressive disorder (MDD) and chronic neuropathic pain. By leveraging the precision of nTMS technology, the NBT system allows for targeted therapy that can lead to significant improvements in patients' symptoms, enhancing their quality of life.

• Navigated Brain Stimulation (NBS) system

The Navigated Brain Stimulation system represents the forefront of pre-surgical brain mapping technology. Utilizing nTMS, the NBS system accurately maps the speech and motor cortices of the brain. This capability is critical for neurosurgeons, providing them with valuable information to plan surgeries with the highest degree of precision, minimizing risks, and preserving essential functions.